Johnson & Johnson is trading 3.14% up at $274.52, with the move appearing mainly driven by improved sentiment as election uncertainty eased.
- Democrats gained control of both chambers of Congress; major indexes and healthcare shares also advanced.
- Positive Shockwave Javelin study results were announced on November 1, but available reporting does not establish them as the direct reason for the November 4 move.